Biomarkers and clinical trials in ALS

被引：0
|
作者：
Genge, Angela [1 ]
机构：
[1] Montreal Neurol Inst, Clin Res Unit, Montreal, PQ, Canada
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2023年 / 455卷
关键词：
D O I：
10.1016/j.jns.2023.120979
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
120979
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prospective clinical trials to investigate clinical and molecular biomarkers
    Auvin, Stehane
    Walker, Lauren
    Gallentine, William
    Jozwiak, Sergiusz
    Tombini, Mario
    Sills, Graeme J.
    [J]. EPILEPSIA, 2017, 58 : 20 - 26
  • [32] Assessing clinical utility and clinical validity of biomarkers in clinical trials
    Caldas, C.
    [J]. BREAST, 2023, 68 : S3 - S3
  • [33] Scrutinizing enrollment in ALS clinical trials: Room for improvement?
    Bedlack, Richard S.
    Pastula, Daniel
    Welsh, Emily
    Pulley, Darlene
    Cudkowicz, Merit E.
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2008, 9 (05): : 257 - 265
  • [34] FTD and ALS—translating mouse studies into clinical trials
    Lars M. Ittner
    Glenda M. Halliday
    Jillian J. Kril
    Jürgen Götz
    John R. Hodges
    Matthew C. Kiernan
    [J]. Nature Reviews Neurology, 2015, 11 : 360 - 366
  • [35] CAN WE ELIMINATE PLACEBO IN ALS CLINICAL TRIALS?
    Simmons, Zachary
    [J]. MUSCLE & NERVE, 2009, 39 (06) : 861 - 865
  • [36] Scrutinizing enrollment in ALS clinical trials: Room for improvement?
    Bedlack, Richard S.
    Pastuala, Daniel
    Welsh, Elizabeth
    Pulley, Darlene
    Cudkowicz, Merit
    [J]. NEUROLOGY, 2008, 70 (11) : A344 - A344
  • [37] Neuroprotective agents for clinical trials in ALS: A systematic assessment
    Burke, William J.
    [J]. NEUROLOGY, 2007, 68 (09) : 709 - 709
  • [38] Motor unit number estimation, ALS and clinical trials
    Gooch, CL
    Harati, Y
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2000, 1 (02): : 71 - 82
  • [39] Can we eliminate placebo in ALS clinical trials?
    Bryan, WW
    Hoagland, RJ
    Murphy, J
    Armon, C
    Barohn, RJ
    Goodpasture, JC
    Miller, RG
    Parry, GJ
    Petajan, JH
    Ross, MA
    Stromatt, SC
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2003, 4 (01): : 11 - 15
  • [40] Neuroprotective agents for clinical trials in ALS - A systematic assessment
    Traynor, B. J.
    Bruijn, L.
    Conwit, R.
    Beal, F.
    O'Neill, G.
    Fagan, C.
    Cudkowicz, M. E.
    [J]. NEUROLOGY, 2006, 67 (01) : 20 - 27
12345